‘Transparency-Rx’ Execs Explain Why They’re Breaking Rank, Backing PBM Reform
-
Sep 28, 2023
As PBMs continue to face an onslaught of regulatory scrutiny, their main trade group — the Pharmaceutical Care Management Association (PCMA) — has been arguing that attempts to alter the industry’s dominant business practices would do nothing but hand Big Pharma a victory and erode PBMs’ ability to bring down drug prices.
Now, however, a new coalition of smaller PBMs that promote a “transparent” business model has entered the scene and is aligning itself not with PCMA, but with attempts to overhaul the PBM industry.
Read more© 2024 MMIT
The Latest
Meet Our Reporters
Meet Our Reporters
GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND
Sign up for publications to get unmatched business intelligence delivered to your inbox.